Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study

被引:14
|
作者
Tedeschi, G. [1 ,2 ]
Dinacci, D. [1 ]
Comerci, M. [3 ]
Lavorgna, L. [1 ]
Savettieri, G. [4 ]
Quattrone, A. [5 ]
Livrea, P. [6 ]
Patti, F. [7 ]
Morra, V. Brescia [8 ]
Servillo, G. [1 ]
Orefice, G. [8 ]
Paciello, M. [9 ]
Prinster, A. [3 ]
Coniglio, G. [9 ]
Bonavita, S. [1 ,2 ]
Di Costanzo, A. [1 ]
Bellacosa, A. [6 ]
Valentino, P. [5 ]
Quarantelli, M. [3 ]
Brunetti, A. [3 ,10 ]
Salemi, G.
D'Amelio, M. [4 ]
Simone, I. [6 ]
Salvatore, M. [3 ,10 ]
Bonavita, V. [2 ,8 ]
Alfano, B. [3 ]
机构
[1] Univ Naples 2, Dept Neurol Sci, I-80138 Naples, Italy
[2] Inst Hermitage Capodimonte, Naples, Italy
[3] CNR, Inst Biostruct & Bioimaging, Naples, Italy
[4] Univ Palermo, Dept Neurol, Palermo, Italy
[5] Univ Catanzaro, Dept Neurol, Catanzaro, Italy
[6] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy
[7] Univ Catania, Dept Neurol, Catania, Italy
[8] Univ Naples Federico II, Dept Neurol Sci, Naples, Italy
[9] San Carlo Hosp, Dept Neurol, Potenza, Italy
[10] Univ Naples Federico II, Dept Diagnost Imaging, Naples, Italy
关键词
atrophy; MRI; multiple sclerosis; T2; lesions; FUNCTIONAL CORTICAL CHANGES; WHITE-MATTER CHANGES; GRAY-MATTER; AUTOMATED SEGMENTATION; CEREBRAL ATROPHY; DISABILITY; PATHOGENESIS; VOLUME; MRI; MS;
D O I
10.1177/1352458508098270
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background To investigate in a large cohort of patients with multiple sclerosis (MS), lesion load and atrophy evolution, and the relationship between clinical and magnetic resonance imaging (MRI) correlates of disease progression. Methods Two hundred and sixty-seven patients with MS were studied at baseline and two years later using the same MRI protocol. Abnormal white matter fraction, normal appearing white matter fraction, global white matter fraction, gray matter fraction and whole brain fraction, T2-hyperintense, and T1-hypointense lesions were measured at both time points. Results The majority of patients were clinically stable, whereas MRI-derived brain tissue fractions were significantly different after 2 years. The correlation between MRI data at baseline and their variation during the follow-up showed that lower basal gray matter atrophy was significantly related with higher progression of gray matter atrophy during follow-up. The correlation between MRI parameters and disease duration showed that gray matter atrophy rate decreased with increasing disease duration, whereas the rate of white matter atrophy had a constant pattern. Lower basal gray matter atrophy was associated with increased probability of developing gray matter atrophy at follow-up, whereas gray matter atrophy progression over 2 years and new T2 lesion load were risk factors for whole brain atrophy progression. Conclusions In MS, brain atrophy occurs even after a relatively short period of time and in patients with limited progression of disability. Short-term brain atrophy progression rates differ across tissue compartments, as gray matter atrophy results more pronounced than white matter atrophy and appears to be a early phenomenon in the MS-related disease progression. Multiple Sclerosis 2009; 15: 204-211. http://msj.sagepub.com
引用
收藏
页码:204 / 211
页数:8
相关论文
共 50 条
  • [21] Sexual dysfunction in multiple sclerosis: A 6-year follow-up study
    Darija, Kisic-Tepavcevic
    Tatjana, Pekmezovic
    Goran, Trajkovic
    Nebojsa, Stojsavljevic
    Irena, Dujmovic
    Sarlota, Mesaros
    Jelena, Drulovic
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 358 (1-2) : 317 - 323
  • [22] Functional Disability and Brain MRI Volumetry Results among Multiple Sclerosis Patients during 5-Year Follow-Up
    Strautmane, Sintija
    Balodis, Arturs
    Teivane, Agnete
    Grabovska, Dagnija
    Naudins, Edgars
    Urbanovics, Daniels
    Fisermans, Edgars
    Mednieks, Janis
    Flintere-Flinte, Alina
    Priede, Zanda
    Millers, Andrejs
    Zolovs, Maksims
    MEDICINA-LITHUANIA, 2023, 59 (06):
  • [23] Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
    Maria Petracca
    Serena Ruggieri
    Elena Barbuti
    Antonio Ianniello
    Roberta Fantozzi
    Giorgia Teresa Maniscalco
    Vincenzo Andreone
    Doriana Landi
    Girolama Alessandra Marfia
    Maria Di Gregorio
    Rosa Iodice
    Leonardo Sinisi
    Elisabetta Maida
    Rosanna Missione
    Cinzia Coppola
    Simona Bonavita
    Giovanna Borriello
    Diego Centonze
    Giacomo Lus
    Carlo Pozzilli
    Elisabetta Signoriello
    Neurology and Therapy, 2022, 11 : 1193 - 1208
  • [24] Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study
    Petracca, Maria
    Ruggieri, Serena
    Barbuti, Elena
    Ianniello, Antonio
    Fantozzi, Roberta
    Maniscalco, Giorgia Teresa
    Andreone, Vincenzo
    Landi, Doriana
    Marfia, Girolama Alessandra
    Di Gregorio, Maria
    Iodice, Rosa
    Sinisi, Leonardo
    Maida, Elisabetta
    Missione, Rosanna
    Coppola, Cinzia
    Bonavita, Simona
    Borriello, Giovanna
    Centonze, Diego
    Lus, Giacomo
    Pozzilli, Carlo
    Signoriello, Elisabetta
    NEUROLOGY AND THERAPY, 2022, 11 (03) : 1193 - 1208
  • [25] Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study
    Lavorgna, L.
    Bonavita, S.
    Ippolito, D.
    Lanzillo, R.
    Salemi, G.
    Patti, F.
    Valentino, P.
    Coniglio, G.
    Buccafusca, M.
    Paolicelli, D.
    d'Ambrosio, A.
    Bresciamorra, V.
    Savettieri, G.
    Zappia, M.
    Alfano, B.
    Gallo, A.
    Simone, I. L.
    Tedeschi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (02) : 220 - 226
  • [26] High-dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis: 2-Year Follow-up (Investigational New Drug No. 65863)
    Gladstone, Douglas E.
    Peyster, Robert
    Baron, Edward
    Friedman-Urevich, Sharon
    Sibony, Patrick
    Melville, Patricia
    Gottesman, Malcolm
    AMERICAN JOURNAL OF THERAPEUTICS, 2011, 18 (01) : 23 - 30
  • [27] Brain atrophy in natalizumab-treated patients: A 3-year follow-up
    Sastre-Garriga, J.
    Tur, C.
    Pareto, D.
    Vidal-Jordana, A.
    Auger, C.
    Rio, J.
    Huerga, E.
    Tintore, M.
    Rovira, A.
    Montalban, X.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 749 - 756
  • [28] Relevance of early cervical cord volume loss in the disease evolution of clinically isolated syndrome and early multiple sclerosis: a 2-year follow-up study
    Inga T. Hagström
    Ruth Schneider
    Barbara Bellenberg
    Anke Salmen
    Florian Weiler
    Odo Köster
    Ralf Gold
    Carsten Lukas
    Journal of Neurology, 2017, 264 : 1402 - 1412
  • [29] Upper cervical cord atrophy is independent of cervical cord lesion volume in early multiple sclerosis: A two-year longitudinal study
    Weeda, Merlin M.
    Zywicki, Sofia
    Brouwer, Iman
    Moraal, Bastiaan
    Killestein, Joep
    Gallo, Paolo
    Barkhof, Frederik
    Pouwels, Petra J. W.
    Vrenken, Hugo
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 60
  • [30] Serial MRI in multiple sclerosis: a prospective pilot study of lesion load, whole brain volume and thalamic atrophy
    Taylor, I
    Butzkueven, H
    Litewka, L
    MacGregor, LR
    Szoeke, C
    Cook, M
    Mitchell, P
    Kilpatrick, TJ
    Tubridy, N
    JOURNAL OF CLINICAL NEUROSCIENCE, 2004, 11 (02) : 153 - 158